![]() |
市場調査レポート
商品コード
1503397
低侵襲手術市場の2030年までの予測:製品タイプ、用途、エンドユーザー、地域別の世界分析Minimally Invasive Surgery Market Forecasts to 2030 - Global Analysis By Product Type, Application, End User and By Geography |
||||||
カスタマイズ可能
|
低侵襲手術市場の2030年までの予測:製品タイプ、用途、エンドユーザー、地域別の世界分析 |
出版日: 2024年06月06日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、世界の低侵襲手術市場は2024年に819億米ドルを占め、予測期間中に13.0%のCAGRで成長し、2030年までに1,705億米ドルに達すると予想されています。
低侵襲手術は、腹腔鏡やロボットシステムなどの先進技術を活用し、小さな切開創から外科手術を行うことで、身体への外傷を軽減します。このアプローチは、従来の開腹手術と比較して、回復時間の短縮、痛みの軽減、瘢痕の減少、合併症のリスクの低下につながります。技術的進歩、侵襲の少ない手術に対する患者の嗜好の高まり、様々な医療分野でのMIS技術の応用拡大により、その普及と発展が成長の原動力となっています。
欧州心臓病学会(ESC)によると、経カテーテル的大動脈弁置換術(TAVR)などの低侵襲心臓手術は、従来の開心術に比べてリスクが低く回復時間が短いため、ますます人気が高まっています。
慢性疾患の増加
心血管障害、がん、糖尿病などの慢性疾患の罹患率の増加が、低侵襲手術の需要を促進しています。これらの手術は、回復時間の短縮、感染リスクの低減、術後疼痛の軽減をもたらし、患者とヘルスケア提供者の双方にとって好ましい選択肢となっています。世界人口の高齢化と慢性疾患の増加に伴い、低侵襲手術手技の需要は大きく伸びると予想されます。
機器と手技の高コスト
ロボット支援手術システムや高精細画像装置などの先端技術は高価であるため、小規模なヘルスケア施設や低所得地域の患者には利用しにくいです。こうしたコストは、特に医療予算に制約のある新興諸国では、低侵襲技術の採用を制限する可能性があります。
ヘルスケアへの投資の増加
ヘルスケア・インフラへの投資の増加と技術の進歩は、低侵襲手術市場にとって大きなチャンスです。政府や民間団体は、先進的な手術器具の開発や医療専門家向けのトレーニングプログラムなど、ヘルスケアプロジェクトへの資金提供を増やしています。こうした投資により、低侵襲手術の利用しやすさと効率が向上し、市場の成長が促進されると期待されています。
合併症のリスク
低侵襲手術には、その利点にもかかわらず、麻酔による合併症、感染症、周辺組織への偶発的損傷などのリスクが伴う。こうした潜在的な合併症は、患者やヘルスケア提供者が低侵襲技術を選択することを躊躇させる可能性があります。さらに、これらの手技を行うには専門的な訓練や専門知識が必要なため、普及が制限され、市場成長の脅威となる可能性があります。
COVID-19の流行は低侵襲手術市場に大きな影響を与えました。COVID-19患者を優先するために選択手術が延期または中止され、一時的な需要減退につながった。しかし、このパンデミックは、入院期間を短縮し、患者が感染症にさらされるのを最小限に抑えるという低侵襲手技の重要性をも浮き彫りにしました。
予測期間中、腹腔鏡機器分野が最大になる見込み
腹腔鏡器具セグメントは、胃腸、婦人科、泌尿器科手術を含む様々な外科手術で広く使用されているため、予測期間中に最大の市場シェアを記録すると予想されています。これらの器具は、精密さ、回復時間の短縮、最小限の傷跡を提供し、外科医や患者の間で高い人気を集めています。腹腔鏡技術の絶え間ない進歩と腹腔鏡手術の増加がこのセグメントの成長を牽引しています。
外来手術センター分野は予測期間中最も高いCAGRが見込まれる
外来手術センター(ASCs)分野は予測期間中に最も高いCAGRが見込まれます。ASCは、従来の病院ベースの手術に代わる費用対効果の高い便利な選択肢を提供し、手術時間の短縮と患者の早期回復を実現します。外来手術への嗜好の高まりと低侵襲技術の進歩が、ASCの急成長を後押ししています。加えて、ASCの増加や有利な償還政策も同分野の拡大に寄与しています。
北米は、高度なヘルスケアインフラ、革新的な手術技術の採用率の高さ、主要市場プレイヤーの存在により、低侵襲手術市場を独占する立場にあります。同地域の確立されたヘルスケアシステムと研究開発への多額の投資は、同市場のトップシェアに貢献しています。さらに、慢性疾患の罹患率が高く、低侵襲手術の需要が高まっていることも、北米市場の成長を後押ししています。
アジア太平洋地域は、ヘルスケア支出の増加、低侵襲手技に対する意識の高まり、医療インフラの改善などにより、低侵襲手術市場の急成長が見込まれています。中国、インド、日本のような国々は、ヘルスケアと技術の進歩に多額の投資を行っており、これが低侵襲手術の採用を後押しすると予想されています。医療観光産業の成長と慢性疾患の蔓延も、この地域の高いCAGRに寄与しています。
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
According to Stratistics MRC, the Global Minimally Invasive Surgery Market is accounted for $81.9 billion in 2024 and is expected to reach $170.5 billion by 2030 growing at a CAGR of 13.0% during the forecast period. Minimally Invasive Surgery involves performing surgical procedures through small incisions, utilizing advanced technologies like laparoscopes and robotic systems, to reduce trauma to the body. This approach leads to shorter recovery times, less pain, reduced scarring, and a lower risk of complications compared to traditional open surgery. The growth is driven by technological advancements, increasing patient preference for less invasive procedures, and the expanding applications of MIS techniques across various medical fields, resulting in their widespread adoption and development.
According to the European Society of Cardiology (ESC), minimally invasive cardiac surgeries, such as transcatheter aortic valve replacement (TAVR), have become increasingly popular due to their lower risk and shorter recovery times compared to traditional open-heart surgeries.
Increasing prevalence of chronic diseases
The rising incidence of chronic diseases such as cardiovascular disorders, cancer, and diabetes is driving the demand for minimally invasive surgeries. These procedures offer reduced recovery times, lower risk of infection, and less postoperative pain, making them a preferred choice for both patients and healthcare providers. As the global population ages and the prevalence of chronic conditions increases, the demand for minimally invasive surgical techniques is expected to grow significantly.
High cost of equipment and procedures
Advanced technologies such as robotic-assisted surgery systems and high-definition imaging devices are expensive, making them less accessible to smaller healthcare facilities and patients in low-income regions. These costs can limit the adoption of minimally invasive techniques, particularly in developing countries where healthcare budgets are constrained.
Increasing investment in healthcare
Growing investments in healthcare infrastructure and technological advancements present significant opportunities for the minimally invasive surgery market. Governments and private entities are increasingly funding healthcare projects, including the development of advanced surgical tools and training programs for medical professionals. These investments are expected to enhance the accessibility and efficiency of minimally invasive procedures, driving market growth.
Risk of complications
Despite the benefits, minimally invasive surgeries carry risks such as complications from anesthesia, infections, and accidental damage to surrounding tissues. These potential complications can deter patients and healthcare providers from opting for minimally invasive techniques. Additionally, the need for specialized training and expertise to perform these procedures can limit their widespread adoption, posing a threat to market growth.
The COVID-19 pandemic significantly impacted the minimally invasive surgery market. Elective surgeries were postponed or canceled to prioritize Covid-19 patients, leading to a temporary decline in demand. However, the pandemic also highlighted the importance of minimally invasive techniques in reducing hospital stays and minimizing patient exposure to infections, which is expected to drive long-term growth in the market.
The laparoscopic instruments segment is expected to be the largest during the forecast period
The laparoscopic instruments segment is expected to register largest market share during the forecast period due to their widespread use in various surgical procedures, including gastrointestinal, gynecological, and urological surgeries. These instruments offer precision, reduced recovery times, and minimal scarring, making them highly popular among surgeons and patients. The continuous advancements in laparoscopic technology and the increasing number of laparoscopic procedures are driving the growth of this segment.
The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period
The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period. ASCs offer cost-effective and convenient alternatives to traditional hospital-based surgeries, with shorter procedure times and faster patient recovery. The growing preference for outpatient surgeries, coupled with advancements in minimally invasive techniques, is driving the rapid growth of ASCs. Additionally, the increasing number of ASCs and favorable reimbursement policies are contributing to the segment's expansion.
North America is positioned to dominate the minimally invasive surgery market due to its advanced healthcare infrastructure, high adoption of innovative surgical technologies, and the presence of key market players. The region's well-established healthcare system and significant investments in research and development contribute to its leading market share. Additionally, the high prevalence of chronic diseases and the increasing demand for minimally invasive procedures further drive market growth in North America.
The Asia Pacific region anticipates rapid growth in the minimally invasive surgery market, driven by the increasing healthcare expenditure, rising awareness about minimally invasive techniques, and improving healthcare infrastructure. Countries like China, India, and Japan are witnessing significant investments in healthcare and technological advancements, which are expected to boost the adoption of minimally invasive surgeries. The growing medical tourism industry and the increasing prevalence of chronic diseases also contribute to the region's high CAGR.
Key players in the market
Some of the key players in Minimally Invasive Surgery Market include Medtronic plc, Johnson & Johnson (Ethicon), Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew plc, Zimmer Biomet Holdings, Inc., Intuitive Surgical, Inc., Abbott Laboratories, B. Braun Melsungen AG, ConMed Corporation, Karl Storz SE & Co. KG, Cook Medical, Applied Medical Resources Corporation, Richard Wolf GmbH, FUJIFILM Holdings Corporation, HOYA Corporation, Teleflex Incorporated, Arthrex, Inc. and NuVasive, Inc.
In March 2023, Medtronic received FDA clearance for its Steerable Flex Robotic Clip Applier used with the Hugo system for minimally invasive gynecologic procedures.
In January 2023, Ethicon launched the ECHELON+ Stapler for minimally invasive colorectal, gastric, and thoracic surgeries.
In January 2023, Boston Scientific received FDA approval for its EXALT Model D Single-Use Duodenoscope for minimally invasive endoscopic procedures.